WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience Introducing ALZET?ew Model 2006 Pump
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

The Journal of Neuroscience, September 28, 2005, 25(39):8898-8902; doi:10.1523/JNEUROSCI.2693-05.2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (26)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Comery, T. A.
Right arrow Articles by Marquis, K. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Comery, T. A.
Right arrow Articles by Marquis, K. L.

 Previous Article  |  Next Article 

BRIEF COMMUNICATION
Acute {gamma}-Secretase Inhibition Improves Contextual Fear Conditioning in the Tg2576 Mouse Model of Alzheimer's Disease

Thomas A. Comery,1 Robert L. Martone,1 Suzan Aschmies,1 Kevin P. Atchison,1 George Diamantidis,2 Xiaohai Gong,1 Hua Zhou,1 Anthony F. Kreft,2 Menelas N. Pangalos,1 June Sonnenberg-Reines,1 J. Steven Jacobsen,1 and Karen L. Marquis1

1Discovery Neuroscience and 2Chemical and Screening Sciences, Wyeth Research, CN8000, Princeton, New Jersey 08543

Transgenic mice (Tg2576) overexpressing the Swedish mutation of the human amyloid precursor protein display biochemical, pathological, and behavioral markers consistent with many aspects of Alzheimer's disease, including impaired hippocampal function. Impaired, hippocampal-dependent, contextual fear conditioning (CFC) is observed in mice as young as 20 weeks of age. This impairment can be attenuated after treatment before training with the phosphodiesterase-4 inhibitor rolipram (0.1 mg/kg, i.p.). A rolipram-associated improvement is also observed in the littermate controls, suggesting that the effect of rolipram is independent of {beta}-amyloid. Acute treatment before training (but not after training or before testing) with the {gamma}-secretase inhibitor (GSI) N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine-t-butylester (DAPT), at a dose that reduces brain concentrations of {beta}-amyloid (100 mg/kg), attenuates the impairment in 20- to 65-week-old Tg2576 mice. Importantly, DAPT had no effect on performance of control littermates. These data are supportive of a role of {beta}-amyloid in the impairment of CFC in Tg2576 mice. Furthermore, they suggest that acute treatment with GSI may provide improved cognitive functioning as well as disease-modifying effects in Alzheimer's disease.

Key words: Alzheimer's disease; amyloid; learning; memory; secretase; dementia


Received Feb 18, 2005; revised June 30, 2005; accepted July 28, 2005.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. S. Jacobsen, T. A. Comery, R. L. Martone, H. Elokdah, D. L. Crandall, A. Oganesian, S. Aschmies, Y. Kirksey, C. Gonzales, J. Xu, et al.
Enhanced clearance of A{beta} in brain by sustaining the plasmin proteolysis cascade
PNAS, June 24, 2008; 105(25): 8754 - 8759.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. T. Teachey, A. E. Seif, V. I. Brown, M. Bruno, R. M. Bunte, Y. J. Chang, J. K. Choi, J. D. Fish, J. Hall, G. S. Reid, et al.
Targeting Notch signaling in autoimmune and lymphoproliferative disease
Blood, January 15, 2008; 111(2): 705 - 714.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
G. Chen, K. S. Chen, D. Kobayashi, R. Barbour, R. Motter, D. Games, S. J. Martin, and R. G. M. Morris
Active {beta}-Amyloid Immunization Restores Spatial Learning in PDAPP Mice Displaying Very Low Levels of {beta}-Amyloid
J. Neurosci., March 7, 2007; 27(10): 2654 - 2662.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
C. L. Masters and K. Beyreuther
Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the A{beta} amyloid pathway
Brain, November 1, 2006; 129(11): 2823 - 2839.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. S. Jacobsen, C.-C. Wu, J. M. Redwine, T. A. Comery, R. Arias, M. Bowlby, R. Martone, J. H. Morrison, M. N. Pangalos, P. H. Reinhart, et al.
Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease
PNAS, March 28, 2006; 103(13): 5161 - 5166.
[Abstract] [Full Text] [PDF]



-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2008 by Society for Neuroscience ONLINE ISSN: 1529-2401
-